OptimizeRx announces $15M stock buyback program through March 2024

OptimizeRx Corp

Board authorized repurchase of up to $15M of common stock.
Program expires March 12, 2024 or when $15M of repurchases completed.
Repurchases may be made in open market or privately negotiated transactions.
Company plans to finance purchases using available cash and cash equivalents.

item 8.01

OptimizeRx Corp filing history →

Source: SEC EDGAR

accession 0001213900-23-019971

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.